| Literature DB >> 22544617 |
Jaqueline Hatsuko Tamashiro-Duran1, Paula Squarzoni, Fábio Luís de Souza Duran, Pedro Kallas Curiati, Homero Pinto Vallada, Carlos Alberto Buchpiguel, Paulo Andrade Lotufo, Mauricio Wajngarten, Paulo Rossi Menezes, Márcia Scazufca, Tânia Corrêa de Toledo Ferraz Alves, Geraldo Filho Busatto.
Abstract
Cardiovascular risk factors (CVRF) possibly contribute to the emergence of Alzheimer's disease (AD). Fluorodeoxyglucose-positron emission tomography (FDG-PET) has been widely used to demonstrate specific patterns of reduced cerebral metabolic rates of glucose (CMRgl) in subjects with AD and in non-demented carriers of the apolipoprotein ε4 (APOE ε4) allele, the major genetic risk factor for AD. However, functional neuroimaging studies investigating the impact of CVRF on cerebral metabolism have been scarce to date. The present FDG-PET study investigated 59 cognitively preserved elderlies divided into three groups according to their cardiovascular risk based on the Framingham 10-year risk Coronary Heart Disease Risk Profile (low-, medium-, and high-risk) to examine whether different levels of CVRF would be associated with reduced CMRgl, involving the same brain regions affected in early stages of AD. Functional imaging data were corrected for partial volume effects to avoid confounding effects due to regional brain atrophy, and all analyses included the presence of the APOE ε4 allele as a confounding covariate. Significant cerebral metabolism reductions were detected in the high-risk group when compared to the low-risk group in the left precuneus and posterior cingulate gyrus. This suggests that findings of brain hypometabolism similar to those seen in subjects with AD can be detected in association with the severity of cardiovascular risk in cognitively preserved individuals. Thus, a greater knowledge about how such factors influence brain functioning in healthy subjects over time may provide important insigths for the future development of strategies aimed at delaying or preventing the vascular-related triggering of pathologic brain changes in the AD.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22544617 PMCID: PMC3636408 DOI: 10.1007/s11357-012-9413-y
Source DB: PubMed Journal: Age (Dordr) ISSN: 0161-9152